NEW YORK (TheStreet) -- Shares of Rite Aid (RAD) - Get Report are are surging about 10% Wednesday after the company announced the acquisition of Envison Pharmaceuticals, a pharmacy benefits manager, for about $2 billion in cash and stock.
Following the acquisition announcement, Cramer says Rite Aid is no longer a turnaround story. Instead, it's now a growth story.
Perhaps the company should consider taking tobacco out of its stores, like CVS Health did as the latter is transitioning into becoming more of a health care company, Cramer said.
Shares of Rite Aid are likely to take out their previous 52-week high of $8.62, as management continues delivering solid results, Cramer added.
-- Written by Bret Kenwell
At the time of publication, Cramer's Action Alerts PLUS was long WBA.